SCHEMBL485061

SCHEMBL485061

Cc1ccc(CC(=O)c2ccc(O)cc2O)cc1Cl

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ESR1 P03372 1/20 0.65
SHBG P04278 1/20 0.65
ESR2 Q92731 1/20 0.65
MAPT P10636 5/20 0.58
RAB9A P51151 4/20 0.58
LMNA P02545 3/20 0.58
SMN1; SMN2 Q16637 2/20 0.58
NPC1 O15118 2/20 0.58
HTT P42858 2/20 0.58
GAA P10253 1/20 0.58
ALOX12 P18054 1/20 0.58
ALDH1A1 P00352 4/20 0.58
HPGD P15428 3/20 0.58
MEN1 O00255 2/20 0.58
KMT2A Q03164 2/20 0.58
ALOX5 P09917 1/20 0.58
CYP3A4 P08684 1/20 0.58
ATM Q13315 1/20 0.58
PIK3CA P42336 2/20 0.54
HSP90AB1 P08238 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9730612 0.87 ESR1 (0.71) ESR1SHBGESR2MAPTRAB9A
SCHEMBL2334134 0.82 MAPT (0.63) ESR1SHBGESR2MAPTRAB9A
SCHEMBL3586687 0.80 ESR1 (0.81) ESR1SHBGESR2MAPTRAB9A
SCHEMBL29514772 0.80 ESR1 (0.81) ESR1SHBGESR2MAPTRAB9A
SCHEMBL38652384 0.80 ESR1 (0.81) ESR1SHBGESR2MAPTRAB9A
SCHEMBL3820741 0.80 ESR1 (0.81) ESR1SHBGESR2MAPTRAB9A
SCHEMBL484705 0.80 ESR1 (0.57) ESR1SHBGESR2MAPTRAB9A
SCHEMBL312243 0.80 ESR1 (1.00) ESR1SHBGESR2MAPTRAB9A
SCHEMBL30503014 0.80 ESR1 (1.00) ESR1SHBGESR2MAPTRAB9A
SCHEMBL3068438 0.79 ESR1 (0.77) ESR1SHBGESR2MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8314132-B2 5-aryl-4-(5-substituted 2,4-dihydroxyphenyl)-1,2,3-thiadiazoles as inhibitors of Hsp90 chaperone and the intermediates for production thereof BIOTECHNOLOGIJOS INSTITUTAS (LT) 2012-11-20 US claimed
EP-2268626-B1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INST (LT) 2012-02-01 EP claimed
US-20110046387-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INSTITUTAS (LT) 2011-02-24 US claimed
EP-2268626-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF Biotechnologijos Institutas (LT) 2011-01-05 EP claimed
WO-2009134110-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF BIOTECHNOLOGIJOS INSTITUTAS (LT) 2009-11-05 WO claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110046387-A1 5-ARYL-4-(5-SUBSTITUTED 2,4-DIHYDROXYPHENYL)-1,2,3-THIADIAZOLES AS INHIBITORS OF HSP90 CHAPERONE AND THE INTERMEDIATES FOR PRODUCTION THEREOF HSP90AB1, HSP90AB2P, HSP90AA1 ESR1 4017/4885SHBG 3779/4885ESR2 3033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.